144 related articles for article (PubMed ID: 22925525)
1. Aqueous calcium sulphate as bone graft for voids following open curettage of bone tumours.
Johnson LJ; Clayer M
ANZ J Surg; 2013 Jul; 83(7-8):564-70. PubMed ID: 22925525
[TBL] [Abstract][Full Text] [Related]
2. Time to full weight-bearing with the use of a calcium sulfate-calcium phosphate bone substitute as a bone void filler following extended curettage in the treatment of primary benign bone tumours.
Gyemi L; Selznick A; Petrisor B; Ghert M
J Orthop Surg (Hong Kong); 2024; 32(2):10225536241254200. PubMed ID: 38733211
[TBL] [Abstract][Full Text] [Related]
3. Injectable Synthetic Beta-Tricalcium Phosphate/Calcium Sulfate (GeneX) for the Management of Contained Defects Following Curettage of Benign Bone Tumours.
Razii N; Docherty LM; Halai M; Mahendra A; Gupta S
Curr Oncol; 2023 Mar; 30(4):3697-3707. PubMed ID: 37185394
[TBL] [Abstract][Full Text] [Related]
4. Long-term Follow-up of the Use of a Synthetic Bone Graft Composite in the Surgical Management of Primary Bone Tumors.
Multani I; Schneider P; Baldawi H; Deheshi B; Ghert M
Orthopedics; 2018 Nov; 41(6):e868-e875. PubMed ID: 30371921
[TBL] [Abstract][Full Text] [Related]
5. No local recurrence of enchondroma after curettage and plaster filling.
Gaasbeek RD; Rijnberg WJ; van Loon CJ; Meyers H; Feith R
Arch Orthop Trauma Surg; 2005 Feb; 125(1):42-5. PubMed ID: 15723246
[TBL] [Abstract][Full Text] [Related]
6. Grafting using injectable calcium sulfate in bone tumor surgery: comparison with demineralized bone matrix-based grafting.
Kim JH; Oh JH; Han I; Kim HS; Chung SW
Clin Orthop Surg; 2011 Sep; 3(3):191-201. PubMed ID: 21909466
[TBL] [Abstract][Full Text] [Related]
7. Use of a calcium sulfate-calcium phosphate synthetic bone graft composite in the surgical management of primary bone tumors.
Evaniew N; Tan V; Parasu N; Jurriaans E; Finlay K; Deheshi B; Ghert M
Orthopedics; 2013 Feb; 36(2):e216-22. PubMed ID: 23380017
[TBL] [Abstract][Full Text] [Related]
8. Use of bone graft substitutes in the management of tibial plateau fractures.
Goff T; Kanakaris NK; Giannoudis PV
Injury; 2013 Jan; 44 Suppl 1():S86-94. PubMed ID: 23351879
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of calcium sulfate artificial bone graft versus allograft in the reconstruction of bone defect after tumor curettage.
Yang Y; Niu X; Zhang Q; Hao L; Ding Y; Xu H
Chin Med J (Engl); 2014; 127(17):3092-7. PubMed ID: 25189951
[TBL] [Abstract][Full Text] [Related]
10. The surgical management of the cavity and bone defects in enchondroma cases: A prospective randomized trial.
Nazarova NZ; Umarova GS; Vaiman M; Asilova SU; Abba M; Foonberg M; Shterenshis M
Surg Oncol; 2021 Jun; 37():101565. PubMed ID: 33848764
[TBL] [Abstract][Full Text] [Related]
11. [Clinical results and the mechanism of bone healing for the repair of bone defects due to tumor resection with novel interporous TCP].
Sang H; Wang Z; Guo Z; Wang L; Li J; Meng G; Li X; Lu J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Apr; 22(4):463-7. PubMed ID: 18575450
[TBL] [Abstract][Full Text] [Related]
12. Treatment of benign and borderline bone tumors with combined curettage and bone defect reconstruction.
Horstmann PF; Hettwer WH; Petersen MM
J Orthop Surg (Hong Kong); 2018; 26(3):2309499018774929. PubMed ID: 30428758
[TBL] [Abstract][Full Text] [Related]
13. Adverse reactions of artificial bone graft substitutes: lessons learned from using tricalcium phosphate geneX®.
Friesenbichler J; Maurer-Ertl W; Sadoghi P; Pirker-Fruehauf U; Bodo K; Leithner A
Clin Orthop Relat Res; 2014 Mar; 472(3):976-82. PubMed ID: 24078171
[TBL] [Abstract][Full Text] [Related]
14. Biphasic bone substitute and fibrin sealant for treatment of benign bone tumours and tumour-like lesions.
Reppenhagen S; Reichert JC; Rackwitz L; Rudert M; Raab P; Daculsi G; Nöth U
Int Orthop; 2012 Jan; 36(1):139-48. PubMed ID: 21626113
[TBL] [Abstract][Full Text] [Related]
15. Bone defects following curettage do not necessarily need augmentation.
Hirn M; de Silva U; Sidharthan S; Grimer RJ; Abudu A; Tillman RM; Carter SR
Acta Orthop; 2009 Feb; 80(1):4-8. PubMed ID: 19234881
[TBL] [Abstract][Full Text] [Related]
16. Chronology of the radiographic appearances of the calcium sulphate-calcium phosphate synthetic bone graft composite following resection of bone tumours--a preliminary study of the normal post-operative appearances.
Kotnis NA; Parasu N; Finlay K; Jurriaans E; Ghert M
Skeletal Radiol; 2011 May; 40(5):563-70. PubMed ID: 20886210
[TBL] [Abstract][Full Text] [Related]
17. Early postoperative compilations of bone filling in curettage defects.
Chen CJ; Brien EW
J Orthop Surg Res; 2019 Aug; 14(1):261. PubMed ID: 31419993
[TBL] [Abstract][Full Text] [Related]
18. The use of a periosteal replacement membrane for bone graft containment at allograft-host junctions after tumor resection and reconstruction with bulk allograft.
Neel M
Orthopedics; 2003 May; 26(5 Suppl):s587-9. PubMed ID: 12755231
[TBL] [Abstract][Full Text] [Related]
19. Composite ceramic bone graft substitute in the treatment of locally aggressive benign bone tumours.
Schindler OS; Cannon SR; Briggs TW; Blunn GW
J Orthop Surg (Hong Kong); 2008 Apr; 16(1):66-74. PubMed ID: 18453663
[TBL] [Abstract][Full Text] [Related]
20. Unexpected radiographic lucency following grafting of bone defects with calcium sulfate/tricalcium phosphate bone substitute.
Auston DA; Feibert M; Craig T; Damron TA
Skeletal Radiol; 2015 Oct; 44(10):1453-9. PubMed ID: 26081807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
